UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

What factors are predictive of benefit finding in women treated for non-metastatic breast cancer? A prospective study

Psycho-oncology (Chichester, England), 2015-05, Vol.24 (5), p.533-539

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Continuation Maintenance Pemetrexed After Cisplatin and Pemetrexed Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Estimates From the Perspective of the Chinese Health Care System

Clinical therapeutics, 2013, Vol.35 (1), p.54-65

2013

Volltextzugriff (PDF)

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis

PloS one, 2014-02, Vol.9 (2), p.e88881-e88881

2014

Volltextzugriff (PDF)

Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer

PharmacoEconomics, 2014-03, Vol.32 (3), p.235-243

2014

Volltextzugriff (PDF)

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy

Clinical therapeutics, 2015-11, Vol.37 (11), p.2515-2526.e5

2015

Volltextzugriff (PDF)

Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China

PloS one, 2013-12, Vol.8 (12), p.e83396

2013

Volltextzugriff (PDF)

TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition

Journal of cellular biochemistry, 2018-01, Vol.119 (1), p.680-690

2018

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide

PharmacoEconomics, 2009-01, Vol.27 (10), p.873-886

2009

Volltextzugriff (PDF)

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway

Cellular signalling, 2021-01, Vol.77, p.109818-109818, Article 109818

2021

Volltextzugriff (PDF)

Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer

Psycho-oncology (Chichester, England), 2014-01, Vol.23 (1), p.93-99

2014

Volltextzugriff (PDF)

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

Clinical cancer research, 2021-08, Vol.27 (16), p.4634-4641

2021

Volltextzugriff (PDF)

Benefit finding predicts depressive and anxious symptoms in women with breast cancer

Quality of life research, 2015-11, Vol.24 (11), p.2681-2688

2015

Volltextzugriff (PDF)

Proteomic analysis reveals that MAEL, a component of nuage, interacts with stress granule proteins in cancer cells

Oncology reports, 2014-01, Vol.31 (1), p.342-350

2014

Volltextzugriff (PDF)

Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer: Cognitive strategies predict depression in women with breast cancer

Psycho-oncology (Chichester, England), 2014-01, Vol.23 (1), p.93-99

2014

Volltextzugriff (PDF)

Cost―Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer: Health Economic Issues in China

PharmacoEconomics, 2014, Vol.32 (3), p.235-243

2014

Volltextzugriff (PDF)

Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer

Zhong nan da xue xue bao. Journal of Central South University. Yi xue ban, 2014-01, Vol.39 (1), p.73-77

2014

Volltextzugriff (PDF)

Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological significance in benign and malignant lesions of breast

Zhong nan da xue xue bao. Journal of Central South University. Yi xue ban, 2010-06, Vol.35 (6), p.584-589

2010

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(14)
Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Breast Cancer
(11)
Female
(10)
Middle Aged
(9)
Oncology
(8)
Cancer
(7)
Adult
(6)
Quality-Adjusted Life Years
(6)
Aged
(5)
Cancer Therapies
(5)
Chemotherapy
(5)
China
(5)
Cost-Benefit Analysis
(5)
Markov Chains
(5)
Sensitivity Analysis
(5)
Antineoplastic Combined Chemotherapy Protocols - Economics
(4)
Breast Neoplasms - Psychology
(4)
Cost Analysis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

What factors are predictive of benefit finding in women treated for non-metastatic breast cancer? A prospective study

Cost-Effectiveness of Continuation Maintenance Pemetrexed After Cisplatin and Pemetrexed Chemotherapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: Estimates From the Perspective of the Chinese Health Care System

Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis

Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy

Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China

Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition

Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway

Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

Benefit finding predicts depressive and anxious symptoms in women with breast cancer

Proteomic analysis reveals that MAEL, a component of nuage, interacts with stress granule proteins in cancer cells

Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer: Cognitive strategies predict depression in women with breast cancer

Cost―Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer: Health Economic Issues in China

Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer

Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological significance in benign and malignant lesions of breast

Suchergebnisse filtern